EMEA-000827-PIP03-11

Key facts

Invented name
Cayston
Active substance
Aztreonam
Therapeutic area
Infectious diseases
Decision number
P/0026/2013
PIP number
EMEA-000827-PIP03-11
Pharmaceutical form(s)
Powder and solvent for nebuliser solution
Condition(s) / indication(s)
Treatment of Gram-negative endobronchial infection in bronchiectasis patients
Route(s) of administration
Inhalation use
Contact for public enquiries
Gilead Sciences International Ltd
E-mail: regulatory.pip@gilead.com
Country: United Kingdom
Tel. +44 (0)1223 897300
Fax +44 (0)1223 897284
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating